Alliqua Biomedical Stock Price, News & Analysis (NASDAQ:ALQA)

$2.02 0.04 (2.02 %)
(As of 01/23/2018 01:03 AM ET)
Previous Close$1.98
Today's Range$1.94 - $2.15
52-Week Range$1.73 - $8.50
Volume190,500 shs
Average Volume212,364 shs
Market Capitalization$10.07 million
P/E Ratio-0.21
Dividend YieldN/A
Beta1.85

About Alliqua Biomedical (NASDAQ:ALQA)

Alliqua Biomedical logoAlliqua BioMedical, Inc. is a provider of advanced wound care solutions. The Company's businesses include advanced wound care and contract manufacturing. The Company operates through its subsidiaries, such as AquaMed Technologies, Inc. and Choice Therapeutics, Inc. The Company is engaged in developing a suite of advanced wound care solutions that will enable surgeons, clinicians and wound care practitioners to address the challenges in chronic and acute wounds. The Company utilizes hydrogel technology through which hydrogels are manufactured by introducing a hydrophilic polymer into water to create a feed mix. The Company's commercial wound care portfolio consists of over four product categories, such as Human Biologics; Antimicrobial Protection; Exudate Management and Contract Manufacturing. Human Biologics include BIOVANCE and Extracellular Matrix (ECM). Under Antimicrobial Protection, the Company offers SilverSeal.

Receive ALQA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALQA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:ALQA
CUSIPN/A
Phone+1-215-7028550

Debt

Debt-to-Equity RatioN/A
Current Ratio0.47%
Quick Ratio0.35%

Price-To-Earnings

Trailing P/E Ratio-0.209761163032191
Forward P/E Ratio-0.52
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.24 million
Price / Sales0.55
Cash FlowN/A
Price / CashN/A
Book Value$10.81 per share
Price / Book0.19

Profitability

Trailing EPS($9.63)
Net Income$-28,240,000.00
Net Margins-155.55%
Return on Equity-110.42%
Return on Assets-65.28%

Miscellaneous

Employees81
Outstanding Shares4,990,000

Alliqua Biomedical (NASDAQ:ALQA) Frequently Asked Questions

What is Alliqua Biomedical's stock symbol?

Alliqua Biomedical trades on the NASDAQ under the ticker symbol "ALQA."

When did Alliqua Biomedical's stock split? How did Alliqua Biomedical's stock split work?

Alliqua Biomedical's stock reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua Biomedical stock prior to the reverse split would have 10 shares after the split.

How were Alliqua Biomedical's earnings last quarter?

Alliqua Biomedical Inc (NASDAQ:ALQA) posted its earnings results on Thursday, November, 9th. The company reported ($0.79) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.76. Alliqua Biomedical had a negative return on equity of 110.42% and a negative net margin of 155.55%. View Alliqua Biomedical's Earnings History.

Where is Alliqua Biomedical's stock going? Where will Alliqua Biomedical's stock price be in 2018?

3 analysts have issued twelve-month price objectives for Alliqua Biomedical's stock. Their forecasts range from $2.80 to $15.00. On average, they expect Alliqua Biomedical's share price to reach $10.10 in the next twelve months. View Analyst Ratings for Alliqua Biomedical.

Who are some of Alliqua Biomedical's key competitors?

Who are Alliqua Biomedical's key executives?

Alliqua Biomedical's management team includes the folowing people:

  • David Ian Johnson, President, Chief Executive Officer, Director (Age 59)
  • Brian M. Posner CPA, Chief Financial Officer, Treasurer, Secretary (Age 55)
  • Bradford C. Barton, Chief Operating Officer (Age 56)
  • Nino Pionati, Chief Strategy & Marketing Officer (Age 59)
  • Gary C. Restani, Director (Age 70)
  • Mark T. Wagner, Director (Age 60)
  • Joseph M. Leone, Independent Director (Age 63)
  • Jeffrey Sklar M.D., Independent Director (Age 54)

How do I buy Alliqua Biomedical stock?

Shares of Alliqua Biomedical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Alliqua Biomedical's stock price today?

One share of Alliqua Biomedical stock can currently be purchased for approximately $2.02.

How big of a company is Alliqua Biomedical?

Alliqua Biomedical has a market capitalization of $10.07 million and generates $18.24 million in revenue each year. The company earns $-28,240,000.00 in net income (profit) each year or ($9.63) on an earnings per share basis. Alliqua Biomedical employs 81 workers across the globe.

How can I contact Alliqua Biomedical?

Alliqua Biomedical's mailing address is 1010 Stony Hill Rd Ste 200, YARDLEY, PA 19067-5545, United States. The company can be reached via phone at +1-215-7028550 or via email at [email protected]


MarketBeat Community Rating for Alliqua Biomedical (ALQA)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  191 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  302
MarketBeat's community ratings are surveys of what our community members think about Alliqua Biomedical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Alliqua Biomedical (NASDAQ:ALQA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.673.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $10.10$14.17$14.17$14.17
Price Target Upside: 300.79% upside322.89% upside322.89% upside264.74% upside

Alliqua Biomedical (NASDAQ:ALQA) Consensus Price Target History

Price Target History for Alliqua Biomedical (NASDAQ:ALQA)

Alliqua Biomedical (NASDAQ:ALQA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/8/2018HC WainwrightDowngradeBuy -> Neutral$4.50 -> $2.80HighView Rating Details
4/11/2017CowenReiterated RatingOutperform$15.00LowView Rating Details
3/8/2017Chardan CapitalLower Price TargetBuy -> Buy$20.00 -> $12.50HighView Rating Details
2/26/2016Northland SecuritiesLower Price TargetOutperform$70.00 -> $30.00N/AView Rating Details
2/26/2016Craig HallumLower Price TargetBuy$30.00N/AView Rating Details
2/24/2016Royal Bank of CanadaLower Price TargetOutperform$60.00 -> $30.00N/AView Rating Details
(Data available from 1/23/2016 forward)

Earnings

Alliqua Biomedical (NASDAQ:ALQA) Earnings History and Estimates Chart

Earnings by Quarter for Alliqua Biomedical (NASDAQ:ALQA)

Alliqua Biomedical (NASDAQ ALQA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017Q3 2017($0.03)($0.79)ViewN/AView Earnings Details
8/10/2017Q2 2017($1.40)($0.90)$5.01 million$5.52 millionViewN/AView Earnings Details
5/9/2017Q1 2017($1.30)($1.70)$4.62 million$4.59 millionViewListenView Earnings Details
3/7/2017Q4 2016($1.90)($1.80)$5.18 million$4.94 millionViewListenView Earnings Details
11/4/2016Q3 2016($2.40)($2.00)$4.85 million$4.87 millionViewN/AView Earnings Details
8/9/2016Q216($2.70)$0.50$5.38 million$5.50 millionViewN/AView Earnings Details
5/10/2016Q116($2.50)($2.80)$4.99 million$4.60 millionViewListenView Earnings Details
2/23/2016Q4($2.80)($1.80)$5.30 million$4.80 millionViewListenView Earnings Details
11/5/2015Q315($2.90)($2.50)$5.44 million$5.00 millionViewN/AView Earnings Details
8/6/2015Q215($3.00)($2.70)$2.85 million$3.10 millionViewN/AView Earnings Details
5/14/2015Q115($3.40)($3.40)$2.37 million$2.10 millionViewListenView Earnings Details
2/24/2015Q414($3.10)($3.40)$1.77 million$1.66 millionViewN/AView Earnings Details
10/30/2014Q3 14($3.10)($3.30)$1.49 millionViewN/AView Earnings Details
8/11/2014Q2 2014($3.80)ViewN/AView Earnings Details
5/12/2014Q1 2014($7.20)ViewN/AView Earnings Details
3/24/2014Q313($2.30)($16.80)$0.40 million$0.47 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Alliqua Biomedical (NASDAQ:ALQA) Earnings Estimates

Current Year EPS Consensus Estimate: $-3.85 EPS
Next Year EPS Consensus Estimate: $5.14 EPS

Dividends

Dividend History for Alliqua Biomedical (NASDAQ:ALQA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Alliqua Biomedical (NASDAQ ALQA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 15.80%
Insider Trades by Quarter for Alliqua Biomedical (NASDAQ:ALQA)
Institutional Ownership by Quarter for Alliqua Biomedical (NASDAQ:ALQA)

Alliqua Biomedical (NASDAQ ALQA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/3/2017Bradford BartonCOOBuy75,000$0.40$30,000.00320,643View SEC Filing  
4/3/2017David Ian JohnsonInsiderBuy250,000$0.40$100,000.001,194,535View SEC Filing  
4/3/2017Mark T WagnerDirectorBuy62,500$0.40$25,000.0070,500View SEC Filing  
2/27/2017Corp /De/ CelgeneMajor ShareholderBuy4,000,000$0.50$2,000,000.007,046,100View SEC Filing  
2/27/2017Jerome B ZeldisDirectorBuy400,000$0.50$200,000.00686,750View SEC Filing  
11/9/2015Brian M PosnerCFOBuy5,000$3.04$15,200.00116,881View SEC Filing  
11/6/2015Bradford BartonCOOBuy5,000$2.97$14,850.00120,985View SEC Filing  
11/6/2015David Ian JohnsonCEOBuy8,650$2.92$25,258.00584,603View SEC Filing  
11/6/2015Jerome B ZeldisDirectorBuy14,000$2.91$40,740.00286,750View SEC Filing  
11/6/2015Pellegrino PionatiInsiderBuy10,000$2.95$29,500.00116,512View SEC Filing  
8/10/2015Brian M PosnerCFOBuy2,500$5.02$12,550.00View SEC Filing  
6/8/2015Bradford BartonCOOBuy3,000$5.25$15,750.00View SEC Filing  
5/27/2015David Ian JohnsonCEOBuy10,000$4.65$46,500.00View SEC Filing  
5/20/2015Brian M PosnerCFOBuy2,500$4.34$10,850.00View SEC Filing  
5/4/2015Corp /De/ CelgeneMajor ShareholderBuy659,340$4.55$2,999,997.00View SEC Filing  
9/15/2014Brian M PosnerCFOBuy2,000$4.94$9,880.00View SEC Filing  
5/13/2014Brian M PosnerCFOBuy3,000$6.92$20,760.00View SEC Filing  
4/14/2014Corp /De/ CelgeneMajor ShareholderBuy714,286$7.00$5,000,002.00View SEC Filing  
5/21/2013Kenneth L LondonerDirectorBuy219,500$0.07$15,365.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Alliqua Biomedical (NASDAQ ALQA) News Headlines

Source:
DateHeadline
Atrion (ATRI) versus Alliqua Biomedical (ALQA) Head to Head AnalysisAtrion (ATRI) versus Alliqua Biomedical (ALQA) Head to Head Analysis
www.americanbankingnews.com - January 14 at 11:30 AM
Wired News – Alliqua BioMedical Enters into Purchase Agreement with Celularity; Agrees to Sell its Advanced Biologic Wound Care BusinessWired News – Alliqua BioMedical Enters into Purchase Agreement with Celularity; Agrees to Sell its Advanced Biologic Wound Care Business
finance.yahoo.com - January 9 at 11:10 AM
Alliqua Biomedical Inc (ALQA) Expected to Post Quarterly Sales of $5.43 MillionAlliqua Biomedical Inc (ALQA) Expected to Post Quarterly Sales of $5.43 Million
www.americanbankingnews.com - January 8 at 2:26 AM
 Brokerages Anticipate Alliqua Biomedical Inc (ALQA) Will Post Earnings of -$0.55 Per Share Brokerages Anticipate Alliqua Biomedical Inc (ALQA) Will Post Earnings of -$0.55 Per Share
www.americanbankingnews.com - January 6 at 11:36 PM
Alliqua BioMedical (ALQA) Reports Purchase of Celularity Inc.s Advanced Biologic Wound Care BusinessAlliqua BioMedical (ALQA) Reports Purchase of Celularity Inc.'s Advanced Biologic Wound Care Business
www.streetinsider.com - January 6 at 10:40 AM
$5.16 Million in Sales Expected for Alliqua Biomedical Inc (ALQA) This Quarter$5.16 Million in Sales Expected for Alliqua Biomedical Inc (ALQA) This Quarter
www.americanbankingnews.com - December 23 at 5:00 AM
Zacks: Analysts Anticipate Alliqua Biomedical Inc (ALQA) Will Post Earnings of -$0.70 Per ShareZacks: Analysts Anticipate Alliqua Biomedical Inc (ALQA) Will Post Earnings of -$0.70 Per Share
www.americanbankingnews.com - December 21 at 3:28 PM
Critical Analysis: Cardiovascular Systems (CSII) vs. Alliqua Biomedical (ALQA)Critical Analysis: Cardiovascular Systems (CSII) vs. Alliqua Biomedical (ALQA)
www.americanbankingnews.com - December 10 at 9:08 PM
 Analysts Anticipate Alliqua Biomedical Inc (ALQA) Will Post Earnings of -$0.70 Per Share Analysts Anticipate Alliqua Biomedical Inc (ALQA) Will Post Earnings of -$0.70 Per Share
www.americanbankingnews.com - December 3 at 5:32 PM
Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017
finance.yahoo.com - December 1 at 5:58 PM
Alliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $5.16 MillionAlliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $5.16 Million
www.americanbankingnews.com - November 17 at 11:08 AM
40 Biggest Movers From Yesterday | Benzinga - Benzinga40 Biggest Movers From Yesterday | Benzinga - Benzinga
www.benzinga.com - November 16 at 11:03 AM
Alliqua BioMedical, Inc. (ALQA) Expected to Announce Earnings of -$0.70 Per ShareAlliqua BioMedical, Inc. (ALQA) Expected to Announce Earnings of -$0.70 Per Share
www.americanbankingnews.com - November 15 at 9:47 AM
Alliqua BioMedical (ALQA) vs. Its Rivals Critical AnalysisAlliqua BioMedical (ALQA) vs. Its Rivals Critical Analysis
www.americanbankingnews.com - November 13 at 9:16 PM
Edited Transcript of ALQA earnings conference call or presentation 9-Nov-17 1:00pm GMTEdited Transcript of ALQA earnings conference call or presentation 9-Nov-17 1:00pm GMT
finance.yahoo.com - November 10 at 2:28 PM
Alliqua BioMedicals (ALQA) CEO David Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaAlliqua BioMedical's (ALQA) CEO David Johnson on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 9 at 4:47 PM
Alliqua, Inc. to Host Earnings CallAlliqua, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 4:47 PM
Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic AlternativesAlliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives
finance.yahoo.com - November 9 at 4:47 PM
Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial OutlookAlliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year 2017 Financial Outlook
finance.yahoo.com - November 9 at 4:47 PM
Alliqua reports 3Q lossAlliqua reports 3Q loss
finance.yahoo.com - November 9 at 4:47 PM
Head-To-Head Comparison: Alliqua BioMedical (ALQA) vs. Its CompetitorsHead-To-Head Comparison: Alliqua BioMedical (ALQA) vs. Its Competitors
www.americanbankingnews.com - November 8 at 3:56 PM
Alliqua BioMedical (ALQA) & T2 Biosystems (TTOO) Head to Head ComparisonAlliqua BioMedical (ALQA) & T2 Biosystems (TTOO) Head to Head Comparison
www.americanbankingnews.com - November 8 at 5:28 AM
Reviewing Alliqua BioMedical (ALQA) and Sientra (SIEN)Reviewing Alliqua BioMedical (ALQA) and Sientra (SIEN)
www.americanbankingnews.com - November 4 at 11:59 AM
Reviewing Alliqua BioMedical (ALQA) & Its PeersReviewing Alliqua BioMedical (ALQA) & Its Peers
www.americanbankingnews.com - October 31 at 11:10 PM
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th - GlobeNewswire (press release)Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th - GlobeNewswire (press release)
globenewswire.com - October 30 at 4:41 PM
Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9thAlliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th
finance.yahoo.com - October 30 at 4:41 PM
Reviewing Alliqua BioMedical (ALQA) & The CompetitionReviewing Alliqua BioMedical (ALQA) & The Competition
www.americanbankingnews.com - October 22 at 10:10 AM
Is It Time To Buy Alliqua BioMedical Inc (ALQA)?Is It Time To Buy Alliqua BioMedical Inc (ALQA)?
finance.yahoo.com - October 17 at 9:39 PM
Alliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $4.98 MillionAlliqua BioMedical, Inc. (ALQA) Expected to Post Quarterly Sales of $4.98 Million
www.americanbankingnews.com - October 8 at 1:04 AM
Alliqua BioMedical, Inc. (ALQA) Upgraded at ValuEngineAlliqua BioMedical, Inc. (ALQA) Upgraded at ValuEngine
www.americanbankingnews.com - October 6 at 11:14 PM
 Brokerages Expect Alliqua BioMedical, Inc. (ALQA) to Post -$0.08 EPS Brokerages Expect Alliqua BioMedical, Inc. (ALQA) to Post -$0.08 EPS
www.americanbankingnews.com - October 6 at 10:30 PM
Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewswire (press release)Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewswire (press release)
globenewswire.com - October 5 at 6:13 PM
Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock SplitAlliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split
finance.yahoo.com - October 5 at 6:13 PM
Have Investors Already Priced In Alliqua BioMedical Inc’s (ALQA) Growth?Have Investors Already Priced In Alliqua BioMedical Inc’s (ALQA) Growth?
finance.yahoo.com - September 22 at 2:43 PM
AtriCure (ATRC) versus Alliqua BioMedical (ALQA) Financial ComparisonAtriCure (ATRC) versus Alliqua BioMedical (ALQA) Financial Comparison
www.americanbankingnews.com - September 19 at 6:10 PM
Alliqua BioMedicals (ALQA) "Buy" Rating Reiterated at HC WainwrightAlliqua BioMedical's (ALQA) "Buy" Rating Reiterated at HC Wainwright
www.americanbankingnews.com - September 18 at 10:16 PM
 Analysts Expect Alliqua BioMedical, Inc. (ALQA) Will Announce Earnings of -$0.12 Per Share Analysts Expect Alliqua BioMedical, Inc. (ALQA) Will Announce Earnings of -$0.12 Per Share
www.americanbankingnews.com - September 18 at 4:24 AM
Featured Company News - Pfizer Receives Warning Letter from FDA Highlighting Manufacturing Defects in the EpiPen Administered for AnaphylaxisFeatured Company News - Pfizer Receives Warning Letter from FDA Highlighting Manufacturing Defects in the EpiPen Administered for Anaphylaxis
finance.yahoo.com - September 11 at 4:36 PM
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua ... - GlobeNewswire (press release)Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua ... - GlobeNewswire (press release)
globenewswire.com - September 5 at 11:04 PM
[$$] The Add-On Deal Roundup: Sept. 5[$$] The Add-On Deal Roundup: Sept. 5
finance.yahoo.com - September 5 at 11:03 PM
ETFs with exposure to Alliqua BioMedical, Inc. : September 5, 2017ETFs with exposure to Alliqua BioMedical, Inc. : September 5, 2017
finance.yahoo.com - September 5 at 11:03 PM
Alliqua (ALQA) Sells TheraBond 3D Antimicrobial Barrier Systems Product Line; Updates OutlookAlliqua (ALQA) Sells TheraBond 3D Antimicrobial Barrier Systems Product Line; Updates Outlook
www.streetinsider.com - September 5 at 5:25 PM
Alliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year OutlookAlliqua BioMedical, Inc. Announces the Sale of TheraBond® 3D Antimicrobial Barrier Systems Product Line; Alliqua Updates Fiscal Year Outlook
finance.yahoo.com - September 5 at 5:25 PM
Contrasting Alliqua BioMedical (ALQA) and Tandem Diabetes Care (TNDM)Contrasting Alliqua BioMedical (ALQA) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - September 4 at 10:18 AM
$5.37 Million in Sales Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter$5.37 Million in Sales Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter
www.americanbankingnews.com - September 1 at 3:48 AM
-$0.12 EPS Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter-$0.12 EPS Expected for Alliqua BioMedical, Inc. (ALQA) This Quarter
www.americanbankingnews.com - August 30 at 4:24 PM
Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Alliqua BioMedical, Inc. :ALQA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 5:21 PM
HC Wainwright Reiterates "$2.00" Price Target for Alliqua BioMedical, Inc. (ALQA)HC Wainwright Reiterates "$2.00" Price Target for Alliqua BioMedical, Inc. (ALQA)
www.americanbankingnews.com - August 13 at 3:32 PM
-$0.12 EPS Expected for Alliqua BioMedical, Inc. (NASDAQ:ALQA) This Quarter-$0.12 EPS Expected for Alliqua BioMedical, Inc. (NASDAQ:ALQA) This Quarter
www.americanbankingnews.com - August 12 at 6:12 AM
Edited Transcript of ALQA earnings conference call or presentation 10-Aug-17 12:00pm GMTEdited Transcript of ALQA earnings conference call or presentation 10-Aug-17 12:00pm GMT
finance.yahoo.com - August 10 at 10:13 PM

SEC Filings

Alliqua Biomedical (NASDAQ:ALQA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Alliqua Biomedical (NASDAQ:ALQA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Alliqua Biomedical (NASDAQ ALQA) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.